Abstract

A chimeric protein called Wallerian degeneration slow (WldS) was first discovered in a spontaneous mutant strain of mice that exhibited delayed Wallerian degeneration. This provides a useful tool in elucidating the mechanisms of axon degeneration. Over-expression of WldS attenuates the axon degeneration that is associated with several neurodegenerative disease models, suggesting a new logic for developing a potential protective strategy. At molecular level, although WldS is a fusion protein, the nicotinamide mononucleotide adenylyl transferase 1 (Nmnat1) is required and sufficient for the protective effects of WldS, indicating a critical role of NAD biosynthesis and perhaps energy metabolism in axon degeneration. These findings challenge the proposed model in which axon degeneration is operated by an active programmed process and thus may have important implication in understanding the mechanisms of neurodegeneration. In this review, we will summarize these recent findings and discuss their relevance to the mechanisms of axon degeneration.

References

Adalbert
R.
,
Gillingwater
T.H.
,
Haley
J.E.
,
Bridge
K.
,
Beirowski
B.
,
Berek
L.
,
Wagner
D.
,
Grumme
D.
,
Thomson
D.
,
Celik
A.
A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses
Eur J Neurosci
2005
21
271
277
10.1111/j.1460-9568.2004.03833.x, 15654865

Araki
T.
,
Sasaki
Y.
,
Milbrandt
J.
Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration
Science
2004
305
1010
1013
10.1126/science.1098014, 15310905, 1:CAS:528:DC%2BD2cXmsVGmsbc%3D

Avery
M.A.
,
Sheehan
A.E.
,
Kerr
K.S.
,
Wang
J.
,
Freeman
M.R.
Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration
J Cell Biol
2009
184
501
513
10.1083/jcb.200808042, 19237597, 1:CAS:528:DC%2BD1MXis1amtro%3D

Beirowski
B.
,
Babetto
E.
,
Coleman
M.P.
,
Martin
K.R.
The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model
Eur J Neurosci
2008
28
1166
1179
10.1111/j.1460-9568.2008.06426.x, 18783366

Beirowski
B.
,
Babetto
E.
,
Gilley
J.
,
Mazzola
F.
,
Conforti
L.
,
Janeckova
L.
,
Magni
G.
,
Ribchester
R.R.
,
Coleman
M.P.
Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo
J Neurosci
2009
29
653
668
10.1523/JNEUROSCI.3814-08.2009, 19158292, 1:CAS:528:DC%2BD1MXhsVCntrc%3D

Berger
F.
,
Lau
C.
,
Dahlmann
M.
,
Ziegler
M.
Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms
J Biol Chem
2005
280
36334
36341
10.1074/jbc.M508660200, 16118205, 1:CAS:528:DC%2BD2MXhtFCjtrrK

Bjartmar
C.
,
Wujek
J.R.
,
Trapp
B.D.
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease
J Neurol Sci
2003
206
165
171
10.1016/S0022-510X(02)00069-2, 12559505, 1:STN:280:DC%2BD3s%2FltVartw%3D%3D

Chitnis
T.
,
Imitola
J.
,
Wang
Y.
,
Elyaman
W.
,
Chawla
P.
,
Sharuk
M.
,
Raddassi
K.
,
Bronson
R.T.
,
Khoury
S.J.
Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration
Am J Pathol
2007
170
1695
1712
10.2353/ajpath.2007.060677, 17456775, 1:CAS:528:DC%2BD2sXlvFCnsb0%3D

Coleman
M.
Axon degeneration mechanisms: commonality amid diversity
Nat Rev Neurosci
2005
6
889
898
10.1038/nrn1788, 16224497, 1:CAS:528:DC%2BD2MXhtFKls7bN

Conforti
L.
,
Fang
G.
,
Beirowski
B.
,
Wang
M.S.
,
Sorci
L.
,
Asress
S.
,
Adalbert
R.
,
Silva
A.
,
Bridge
K.
,
Huang
X.P.
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delayWallerian degeneration
Cell Death Differ
2007
14
116
127
10.1038/sj.cdd.4401944, 16645633, 1:CAS:528:DC%2BD28XhtlSqur7J

Conforti
L.
,
Tarlton
A.
,
Mack
T.G.
,
Mi
W.
,
Buckmaster
E.A.
,
Wagner
D.
,
Perry
V.H.
,
Coleman
M.P.
A Ufd2/D4Cole1e chimeric protein and over-expression of Rbp7 in the slow Wallerian degeneration (WldS) mouse
Proc Natl Acad Sci U S A
2000
97
11377
11382
10.1073/pnas.97.21.11377, 11027338, 1:CAS:528:DC%2BD3cXnsF2ru7g%3D

Conforti
L.
,
Wilbrey
A.
,
Morreale
G.
,
Janeckova
L.
,
Beirowski
B.
,
Adalbert
R.
,
Mazzola
F.
,
Di Stefano
M.
,
Hartley
R.
,
Babetto
E.
Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice
J Cell Biol
2009
184
491
500
10.1083/jcb.200807175, 19237596, 1:CAS:528:DC%2BD1MXis1amtr0%3D

Deckwerth
T.L.
,
Johnson
E.M.
Jr.
Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis)
Dev Biol
1994
165
63
72
10.1006/dbio.1994.1234, 8088451, 1:STN:280:DyaK2cznsVGrsA%3D%3D

Emanuelli
M.
,
Amici
A.
,
Carnevali
F.
,
Pierella
F.
,
Raffaelli
N.
,
Magni
G.
Identification and characterization of a second NMN adenylyltransferase gene in Saccharomyces cerevisiae
Protein Expr Purif
2003
27
357
364
10.1016/S1046-5928(02)00645-9, 12597897, 1:CAS:528:DC%2BD3sXht1GitrY%3D

Emanuelli
M.
,
Carnevali
F.
,
Saccucci
F.
,
Pierella
F.
,
Amici
A.
,
Raffaelli
N.
,
Magni
G.
Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase
J Biol Chem
2001
276
406
412
10.1074/jbc.M008700200, 11027696, 1:CAS:528:DC%2BD3MXmtFSkug%3D%3D

Fang
C.
,
Bernardes-Silva
M.
,
Coleman
M.P.
,
Perry
V.H.
The cellular distribution of the Wld s chimeric protein and its constituent proteins in the CNS
Neuroscience
2005
135
1107
1118
10.1016/j.neuroscience.2005.06.078, 16154290, 1:CAS:528:DC%2BD2MXhtVymtr7P

Ferri
A.
,
Sanes
J.R.
,
Coleman
M.P.
,
Cunningham
J.M.
,
Kato
A.C.
Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease
Curr Biol
2003
13
669
673
10.1016/S0960-9822(03)00206-9, 12699624, 1:CAS:528:DC%2BD3sXjtVKhu70%3D

Finn
J.T.
,
Weil
M.
,
Archer
F.
,
Siman
R.
,
Srinivasan
A.
,
Raff
M. C.
Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases
J Neurosci
2000
20
1333
1341
10662823, 1:CAS:528:DC%2BD3cXitVOktbw%3D

Fischer
L.R.
,
Culver
D.G.
,
Davis
A.A.
,
Tennant
P.
,
Wang
M.
,
Coleman
M.
,
Asress
S.
,
Adalbert
R.
,
Alexander
G.M.
,
Glass
J.D.
The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse
Neurobiol Dis
2005
19
293
300
10.1016/j.nbd.2005.01.008, 15837585, 1:CAS:528:DC%2BD2MXjtlajt7w%3D

Gillingwater
T.H.
,
Wishart
T.M.
,
Chen
P.E.
,
Haley
J.E.
,
Robertson
K.
,
Macdonald
S.H.
,
Middleton
S.
,
Wawrowski
K.
,
Shipston
M.J.
,
Melmed
S.
The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells
Hum Mol Genet
2006
15
625
635
10.1093/hmg/ddi478, 16403805, 1:CAS:528:DC%2BD28XhtFaitbo%3D

Glass
J.D.
,
Brushart
T.M.
,
George
E.B.
,
Griffin
J.W.
Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon
J Neurocytol
1993
22
311
321
10.1007/BF01195555, 8315413, 1:STN:280:DyaK3szgtFKntg%3D%3D

Gould
T.W.
,
Buss
R.R.
,
Vinsant
S.
,
Prevette
D.
,
Sun
W.
,
Knudson
C.M.
,
Milligan
C.E.
,
Oppenheim
R.W.
Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS
J Neurosci
2006
26
8774
8786
10.1523/JNEUROSCI.2315-06.2006, 16928866, 1:CAS:528:DC%2BD28Xpt1SrsrY%3D

Gultner
S.
,
Laue
M.
,
Riemer
C.
,
Heise
I.
,
Baier
M.
Prion disease development in slow Wallerian degeneration (Wld(S)) mice
Neurosci Lett
2009
456
93
98
10.1016/j.neulet.2009.03.089, 19429141, 1:CAS:528:DC%2BD1MXltVCmsrw%3D

Haigis
M.C.
,
Guarente
L.P.
Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction
Genes Dev
2006
20
2913
2921
10.1101/gad.1467506, 17079682, 1:CAS:528:DC%2BD28XhtFynu7bJ

Halawani
D.
,
Latterich
M.
p97: The cell’s molecular purgatory
Mol Cell
2006
22
713
717
10.1016/j.molcel.2006.06.003, 16793541, 1:CAS:528:DC%2BD28XmvVCitL4%3D

Hasbani
D.M.
,
O’Malley
K.L.
Wld(S) mice are protected against the Parkinsonian mimetic MPTP
Exp Neurol
2006
202
93
99
10.1016/j.expneurol.2006.05.017, 16806180, 1:CAS:528:DC%2BD28XpslSmtb4%3D

Hilliard
M.A.
Axonal degeneration and regeneration: a mechanistic tug-of-war
J Neurochem
2009
108
23
32
10.1111/j.1471-4159.2008.05754.x, 19054282, 1:CAS:528:DC%2BD1MXns1Wrsg%3D%3D

Hoopfer
E.D.
,
McLaughlin
T.
,
Watts
R.J.
,
Schuldiner
O.
,
O’Leary
D. D.
,
Luo
L.
Wlds protection distinguishes axon degeneration following injury from naturally occurring developmental pruning
Neuron
2006
50
883
895
10.1016/j.neuron.2006.05.013, 16772170, 1:CAS:528:DC%2BD28XmsVOjs74%3D

Jia
H.
,
Yan
T.
,
Feng
Y.
,
Zeng
C.
,
Shi
X.
,
Zhai
Q.
Identification of a critical site in Wld(s): Essential for Nmnat enzyme activity and axon-protective function
Neurosci Lett
2007
413
46
51
10.1016/j.neulet.2006.11.067, 17207927, 1:CAS:528:DC%2BD2sXhtVarsLs%3D

Kaneko
S.
,
Wang
J.
,
Kaneko
M.
,
Yiu
G.
,
Hurrell
J.M.
,
Chitnis
T.
,
Khoury
S.J.
,
He
Z.
Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models
J Neurosci
2006
26
9794
9804
10.1523/JNEUROSCI.2116-06.2006, 16988050, 1:CAS:528:DC%2BD28XhtVCgu7nL

Kariya
S.
,
Mauricio
R.
,
Dai
Y.
,
Monani
U.R.
The neuroprotective factor Wld(s) fails to mitigate distal axonal and neuromuscular junction (NMJ) defects in mouse models of spinal muscular atrophy
Neurosci Lett
2009
449
246
251
10.1016/j.neulet.2008.10.107, 19010394, 1:CAS:528:DC%2BD1cXhsV2gt7rP

Kerschensteiner
M.
,
Schwab
M.E.
,
Lichtman
J.W.
,
Misgeld
T.
In vivo imaging of axonal degeneration and regeneration in the injured spinal cord
Nat Med
2005
11
572
577
10.1038/nm1229, 15821747, 1:CAS:528:DC%2BD2MXjvVOlsro%3D

Koegl
M.
,
Hoppe
T.
,
Schlenker
S.
,
Ulrich
H.D.
,
Mayer
T.U.
,
Jentsch
S.
A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly
Cell
1999
96
635
644
10.1016/S0092-8674(00)80574-7, 10089879, 1:CAS:528:DyaK1MXitVChsrg%3D

Laser
H.
,
Conforti
L.
,
Morreale
G.
,
Mack
T.G.
,
Heyer
M.
,
Haley
J. E.
,
Wishart
T.M.
,
Beirowski
B.
,
Walker
S.A.
,
Haase
G.
The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus
Mol Biol Cell
2006
17
1075
1084
10.1091/mbc.E05-04-0375, 16371511, 1:CAS:528:DC%2BD28XltlSqt78%3D

Lau
C.
,
Niere
M.
,
Ziegler
M.
The NMN/NaMN adenylyltransferase (NMNAT) protein family
Front Biosci
2009
14
410
431
10.2741/3252, 19273075, 1:CAS:528:DC%2BD1MXltFejsLY%3D

Lunn
E.R.
,
Perry
V.H.
,
Brown
M.C.
,
Rosen
H.
,
Gordon
S.
Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve
Eur J Neurosci
1989
1
27
33
10.1111/j.1460-9568.1989.tb00771.x, 12106171, 1:STN:280:DC%2BD1Mjjs1Shtw%3D%3D

Luo
L.
,
O’Leary
D.D.
Axon retraction and degeneration in development and disease
Annu Rev Neurosci
2005
28
127
156
10.1146/annurev.neuro.28.061604.135632, 16022592, 1:CAS:528:DC%2BD2MXosVegtLw%3D

MacDonald
J.M.
,
Beach
M.G.
,
Porpiglia
E.
,
Sheehan
A.E.
,
Watts
R.J.
,
Freeman
M.R.
The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons
Neuron
2006
50
869
881
10.1016/j.neuron.2006.04.028, 16772169, 1:CAS:528:DC%2BD28XmsVOjsrc%3D

MacInnis
B.L.
,
Campenot
R.B.
Regulation of Wallerian degeneration and nerve growth factor withdrawal-induced pruning of axons of sympathetic neurons by the proteasome and the MEK/Erk pathway
Mol Cell Neurosci
2005
28
430
439
10.1016/j.mcn.2004.10.003, 15737734, 1:CAS:528:DC%2BD2MXhslWrtr0%3D

Mack
T.G.
,
Reiner
M.
,
Beirowski
B.
,
Mi
W.
,
Emanuelli
M.
,
Wagner
D.
,
Thomson
D.
,
Gillingwater
T.
,
Court
F.
,
Conforti
L.
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
Nat Neurosci
2001
4
1199
1206
10.1038/nn770, 11770485, 1:CAS:528:DC%2BD3MXovVCqurc%3D

Mi
W.
,
Beirowski
B.
,
Gillingwater
T.H.
,
Adalbert
R.
,
Wagner
D.
,
Grumme
D.
,
Osaka
H.
,
Conforti
L.
,
Arnhold
S.
,
Addicks
K.
The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice
Brain
2005
128
405
416
10.1093/brain/awh368, 15644421

Morrissette
D.A.
,
Parachikova
A.
,
Green
K.N.
,
LaFerla
F.M.
Relevance of transgenic mouse models to human Alzheimer disease
J Biol Chem
2009
284
6033
6037
10.1074/jbc.R800030200, 18948253, 1:CAS:528:DC%2BD1MXisVSksLw%3D

Perry
V.H.
,
Brown
M.C.
,
Lunn
E.R.
,
Tree
P.
,
Gordon
S.
Evidence that very slow Wallerian degeneration in C57BL/Ola mice is an intrinsic property of the peripheral nerve
Eur J Neurosci
1990
2
802
808
10.1111/j.1460-9568.1990.tb00472.x, 12106282, 1:STN:280:DC%2BD1Mjjs1Sgtg%3D%3D

Press
C.
,
Milbrandt
J.
Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress
J Neurosci
2008
28
4861
4871
10.1523/JNEUROSCI.0525-08.2008, 18463239, 1:CAS:528:DC%2BD1cXlvFersbY%3D

Raff
M.C.
,
Whitmore
A.V.
,
Finn
J.T.
Axonal self-destruction and neurodegeneration
Science
2002
296
868
871
10.1126/science.1068613, 11988563, 1:CAS:528:DC%2BD38XjsFOrs7c%3D

Raffaelli
N.
,
Sorci
L.
,
Amici
A.
,
Emanuelli
M.
,
Mazzola
F.
,
Magni
G.
Identification of a novel human nicotinamide mononucleotide adenylyltransferase
Biochem Biophys Res Commun
2002
297
835
840
10.1016/S0006-291X(02)02285-4, 12359228, 1:CAS:528:DC%2BD38XntlSitLw%3D

Revollo
J.R.
,
Grimm
A.A.
,
Imai
S.
The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells
J Biol Chem
2004
279
50754
50763
10.1074/jbc.M408388200, 15381699, 1:CAS:528:DC%2BD2cXhtVaru7vL

Sagot
Y.
,
Dubois-Dauphin
M.
,
Tan
S.A.
,
de Bilbao
F.
,
Aebischer
P.
,
Martinou
J.C.
,
Kato
A.C.
Bcl-2 over-expression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease
J Neurosci
1995
15
7727
7733
7472523, 1:CAS:528:DyaK2MXptlOmtrs%3D

Sagot
Y.
,
Rosse
T.
,
Vejsada
R.
,
Perrelet
D.
,
Kato
A.C.
Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease
J Neurosci
1998
18
1132
1141
9437033, 1:CAS:528:DyaK1cXmtFGltQ%3D%3D

Sajadi
A.
,
Schneider
B.L.
,
Aebischer
P.
WldS-mediated protection of dopaminergic fibers in an animal model of Parkinson disease
Curr Biol
2004
14
326
330
14972684, 1:CAS:528:DC%2BD2cXhsFWrurs%3D

Samsam
M.
,
Mi
W.
,
Wessig
C.
,
Zielasek
J.
,
Toyka
K.V.
,
Coleman
M.P.
,
Martini
R.
The WldS mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy
J Neurosci
2003
23
2833
2839
12684470, 1:CAS:528:DC%2BD3sXjtFCntLg%3D

Sasaki
Y.
,
Araki
T.
,
Milbrandt
J.
Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy
J Neurosci
2006
26
8484
8491
10.1523/JNEUROSCI.2320-06.2006, 16914673, 1:CAS:528:DC%2BD28Xpt1Cks74%3D

Sasaki
Y.
,
Vohra
B.P.
,
Baloh
R.H.
,
Milbrandt
J.
Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration in vivo
J Neurosci
2009
29
6526
6534
10.1523/JNEUROSCI.1429-09.2009, 19458223, 1:CAS:528:DC%2BD1MXmsFentrY%3D

Sasaki
Y.
,
Vohra
B.P.
,
Lund
F.E.
,
Milbrandt
J.
Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide
J Neurosci
2009
29
5525
5535
10.1523/JNEUROSCI.5469-08.2009, 19403820, 1:CAS:528:DC%2BD1MXlvVGls7g%3D

Saxena
S.
,
Caroni
P.
Mechanisms of axon degeneration: from development to disease
Prog Neurobiol
2007
83
174
191
10.1016/j.pneurobio.2007.07.007, 17822833, 1:CAS:528:DC%2BD2sXhtFSntrnK

Schweiger
M.
,
Hennig
K.
,
Lerner
F.
,
Niere
M.
,
Hirsch-Kauffmann
M.
,
Specht
T.
,
Weise
C.
,
Oei
S.L.
,
Ziegler
M.
Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis
FEBS Lett
2001
492
95
100
10.1016/S0014-5793(01)02180-9, 11248244, 1:CAS:528:DC%2BD3MXhvVantr8%3D

Vande Velde
C.
,
Garcia
M.L.
,
Yin
X.
,
Trapp
B.D.
,
Cleveland
D. W.
The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease
Neuromolecular Med
2004
5
193
203
10.1385/NMM:5:3:193, 15626820, 1:CAS:528:DC%2BD2MXot1KktQ%3D%3D

Waller
A.V.
Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations on the alterations produced thereby in the structure of their primitive fibres
Philos Trans RSoc Lond B Biol Sci
1850
140
423
429
10.1098/rstl.1850.0021

Wang
J.
,
Zhai
Q.
,
Chen
Y.
,
Lin
E.
,
Gu
W.
,
McBurney
M.W.
,
He
Z.
A local mechanism mediates NAD-dependent protection of axon degeneration
J Cell Biol
2005
170
349
355
10.1083/jcb.200504028, 16043516, 1:CAS:528:DC%2BD2MXntVaku78%3D

Wang
M.
,
Wu
Y.
,
Culver
D.G.
,
Glass
J.D.
The gene for slow Wallerian degeneration (Wld(s)) is also protective against vincristine neuropathy
Neurobiol Dis
2001
8
155
161
10.1006/nbdi.2000.0334, 11162249, 1:CAS:528:DC%2BD3MXpvVSrsA%3D%3D

Wang
M.S.
,
Davis
A.A.
,
Culver
D.G.
,
Glass
J.D.
WldS mice are resistant to paclitaxel (taxol) neuropathy
Ann Neurol
2002
52
442
447
10.1002/ana.10300, 12325073

Wang
M.S.
,
Fang
G.
,
Culver
D.G.
,
Davis
A.A.
,
Rich
M.M.
,
Glass
J.D.
The WldS protein protects against axonal degeneration: a model of gene therapy for peripheral neuropathy
Ann Neurol
2001
50
773
779
10.1002/ana.10039, 11761475, 1:CAS:528:DC%2BD38Xhs1Kntw%3D%3D

Watanabe
M.
,
Tsukiyama
T.
,
Hatakeyama
S.
Protection of vincristine-induced neuropathy by Wld(S) expression and the independence of the activity of Nmnat1
Neurosci Lett
2007
411
228
232
10.1016/j.neulet.2006.09.068, 17113230, 1:CAS:528:DC%2BD28Xht1KgurjO

Wishart
T.M.
,
Pemberton
H.N.
,
James
S.R.
,
McCabe
C.J.
,
Gillingwater
T.H.
Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds)
Genome Biol
2008
9
R101
10.1186/gb-2008-9-6-r101, 18570652, 1:CAS:528:DC%2BD1cXhtVWjtr3K

Yahata
N.
,
Yuasa
S.
,
Araki
T.
Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration
J Neurosci
2009
29
6276
6284
10.1523/JNEUROSCI.4304-08.2009, 19439605, 1:CAS:528:DC%2BD1MXmt1Cmu70%3D

Yalowitz
J.A.
,
Xiao
S.
,
Biju
M.P.
,
Antony
A.C.
,
Cummings
O.W.
,
Deeg
M.A.
,
Jayaram
H.N.
Characterization of human brain nicotinamide 5’-mononucleotide adenylyltransferase-2 and expression in human pancreas
Biochem J
2004
377
317
326
10.1042/BJ20030518, 14516279, 1:CAS:528:DC%2BD2cXis1Wruw%3D%3D

Yan
,
T.
,
Feng
,
Y.
,
Zheng
,
J.
,
Ge
,
X.
,
Zhang
,
Y.
,
Wu
,
D.
,
Zhao
,
J.
, and
Zhai
,
Q.
(
2009
).
Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity
.
Neurochem Int.
In press.

Yang
H.
,
Yang
T.
,
Baur
J.A.
,
Perez
E.
,
Matsui
T.
,
Carmona
J.J.
,
Lamming
D.W.
,
Souza-Pinto
N.C.
,
Bohr
V.A.
,
Rosenzweig
A.
Nutrient-sensitive mitochondrial NAD + levels dictate cell survival
Cell
2007
130
1095
1107
10.1016/j.cell.2007.07.035, 17889652, 1:CAS:528:DC%2BD2sXhtFKnurjM

Zhai
Q.
,
Wang
J.
,
Kim
A.
,
Liu
Q.
,
Watts
R.
,
Hoopfer
E.
,
Mitchison
T.
,
Luo
L.
,
He
Z.
Involvement of the ubiquitinproteasome system in the early stages of wallerian degeneration
Neuron
2003
39
217
225
10.1016/S0896-6273(03)00429-X, 12873380, 1:CAS:528:DC%2BD3sXlvFyrs7k%3D

Zhai
R.G.
,
Cao
Y.
,
Hiesinger
P.R.
,
Zhou
Y.
,
Mehta
S.Q.
,
Schulze
K.L.
,
Verstreken
P.
,
Bellen
H.J.
Drosophila NMNAT maintains neural integrity independent of its NAD synthesis Activity
PLoS Biol
2006
4
e416
10.1371/journal.pbio.0040416, 17132048, 1:CAS:528:DC%2BD28Xhtlenur7J

Zhai
R.G.
,
Zhang
F.
,
Hiesinger
P.R.
,
Cao
Y.
,
Haueter
C.M.
,
Bellen
H.J.
NAD synthase NMNATacts as a chaperone to protect against neurodegeneration
Nature
2008
452
887
891
10.1038/nature06721, 18344983, 1:CAS:528:DC%2BD1cXkvVSis74%3D

Zhang
X.
,
Kurnasov
O.V.
,
Karthikeyan
S.
,
Grishin
N.V.
,
Osterman
A.L.
,
Zhang
H.
Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis
J Biol Chem
2003
278
13503
13511
10.1074/jbc.M300073200, 12574164, 1:CAS:528:DC%2BD3sXislGqs7k%3D

This content is only available as a PDF.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)